What Underlies PARP Inhibitor Resistance in Ovarian Cancer?

New research examines the mechanisms underlying why most patients with high-grade serous ovarian cancer develop resistance to PARP inhibitors.

Source: CancerNetwork - September 14, 2018 Category: Cancer & Oncology Authors: Mary Beth Nierengarten Source Type: news